NCT03999528View on ClinicalTrials.gov

14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

August 1, 2019

Study Completion Date

August 1, 2019

Conditions
Rheumatoid ArthritisOsteoporosis
Interventions
DIAGNOSTIC_TEST

14-3-3η Protein assay

blood sampling for assessment of serum 14-3-3η Protein

Trial Locations (1)

11311

Al-Azhar Faculty of medicine, Rheumatology Department, Cairo

All Listed Sponsors
lead

Al-Azhar University

OTHER

NCT03999528 - 14-3-3η Protein, Disease Activity and Bone Mineral Density, in Female Patients With Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter